טוען...
Spironolactone Use and Higher Hospital Readmission for Medicare Beneficiaries with Heart Failure, Left Ventricular Ejection Fraction <45% and Estimated Glomerular Filtration Rate <45 ml/min/1.73m(2)
While randomized controlled trials have demonstrated benefits of aldosterone antagonists for patients with heart failure and reduced ejection fraction (HFrEF), they excluded patients with serum creatinine >2.5mg/dl and their use is contraindicated in those with advanced chronic kidney disease (CK...
שמור ב:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4169696/ https://ncbi.nlm.nih.gov/pubmed/24846806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2014.03.062 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|